Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs [NA]

View source ↗

Summary

A University of Cambridge-sponsored clinical trial is exploring strategies to improve beta-cell function with the goal of achieving remission in type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Cambridge | Conditions: Type 2 Diabetes | NA | Status: RECRUITING